Chang et al. found that elevated levels of CK18 (assessed by M30 and M65 assays) in patients with T2D had a significant positive association with fasting plasma glucose levels, and it was independent of NAFLD status [19]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.